Oncology

Oncology is one of the most rapidly evolving therapeutic areas with considerable clinical and economic burden. Health economics and outcomes research in oncology is complicated by (1) the diversity of the epidemiology and biology of various tumors, which limits the sample size and long-term follow-up in clinical trials, (2) the rapidly evolving treatment landscapes and variation in national management recommendations, and (3) the complexities of measuring costs and quality of life in patients and caregivers. Therefore, oncology health economics and outcomes research constitutes a unique segment, and our SIG aims to advance clinical and methodological knowledge for proper clinical and economic evaluation of oncology treatments and diagnostic tools.  

Engage the oncology community to raise awareness of key components in oncology HEOR and recommended practices.

Offer relevant and impactful educational presentations and activities on the latest oncology HEOR topics.

Create a space to support the discussion of methods of statistical analysis and economic evaluation in oncology, and approaches to support timely access of innovative oncology treatments and diagnostic tools.